Cite
HARVARD Citation
Lambert, J. et al. (n.d.). FRI0116 Pharmacokinetic Results from a Phase 1, Single-Centre, Double-Blind, Randomised, Single-Dose, Parallel Group Study Comparing 5 MG/KG IV Infusion of BOW015 and Reference Infliximab in Healthy Male Volunteers. Annals of the rheumatic diseases. p. 462. [Online].